Arian Lasocki

Conventional MRI features can predict the molecular subtype of adult grade 2-3 intracranial diffuse gliomas

Arian Lasocki, Michael E Buckland, Katharine J Drummond, Heng Wei, Jing Xie, Michael Christie, Andrew Neal, Frank Gaillard

Journal article  |  2022  |  NEURORADIOLOGY

PURPOSE: Molecular biomarkers are important for classifying intracranial gliomas, prompting research into correlating imaging with..

Machine learning imaging applications in the differentiation of true tumour progression from treatment-related effects in brain tumours: A systematic review and meta-analysis

Abhishta Bhandari, Ravi Marwah, Justin Smith, Duy Nguyen, Asim Bhatti, Chee Peng Lim, Arian Lasocki

Journal article  |  2022  |  JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY

INTRODUCTION: Chemotherapy and radiotherapy can produce treatment-related effects, which may mimic tumour progression. Advances in..

Neuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy

Adam H Lapidus, Mary Ann Anderson, Simon J Harrison, Michael Dickinson, Tomas Kalincik, Arian Lasocki

Journal article  |  2022  |  LEUKEMIA & LYMPHOMA

Chimeric antigen receptor T-cell (CAR-T) therapy is a promising immunotherapy approved for hematological malignancies. Despite its..

Active surveillance is safe for asymptomatic radiation-induced meningiomas in cancer survivors

M Xu, A Lasocki, M Bressel, N Goroncy, J Seymour, G Wheeler, M Dwyer, K Wiltshire, N Haghighi, K Mason, D Tange, B Campbell

Conference Proceedings  |  2022  |  RADIOTHERAPY AND ONCOLOGY

Central nervous system manifestations of systemic haematological malignancies and key differentials

A Lasocki, JF Seymour

Journal article  |  2022  |  CLINICAL RADIOLOGY

Central nervous system (CNS) involvement by haematological malignancies is uncommon, and generally associated with a poor prognosi..

Part 1: Imaging findings of common immune checkpoint inhibitor-related adverse effects

Geertje Noe, Anthony Cardin, Arian Lasocki

Journal article  |  2022  |  JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY

Over the last decade or so, immunotherapy and in particular immune checkpoint inhibitors have become common in the treatment of nu..

Part 2: Imaging findings of uncommon but important immune checkpoint inhibitor-related adverse effects

Geertje Noe, Anthony Cardin, Arian Lasocki

Journal article  |  2022  |  JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY

Oncology care has significantly changed with the emergence of immunotherapy agents, in particular immune checkpoint inhibitors (IC..

Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)

Peter Kar Han Lau, Breon Feran, Lorey Smith, Arian Lasocki, Ramyar Molania, Kortnye Smith, Alison Weppler, Christopher Angel, Damien Kee, Prachi Bhave, Belinda Lee, Richard J Young, Amir Iravani, Hanxian Aw Yeang, Ismael A Vergara, David Kok, Kate Drummond, Paul Joseph Neeson, Karen E Sheppard, Tony Papenfuss, et al.

Journal article  |  2021  |  JOURNAL FOR IMMUNOTHERAPY OF CANCER

BACKGROUND: Melanoma brain metastases (MBMs) are a challenging clinical problem with high morbidity and mortality. Although first-..

Evaluation of the Impact of Magnetic Resonance Imaging with Susceptibility-weighted Imaging for Screening and Surveillance of Radiation-induced Cavernomas in Long-term Survivors of Malignancy

BA Campbell, A Lasocki, SF Oon, M Bressel, N Goroncy, M Dwyer, K Wiltshire, JF Seymour, K Mason, D Tange, M Xu, G Wheeler

Journal article  |  2021  |  CLINICAL ONCOLOGY

AIMS: Radiation-induced cavernomas (RIC) are common late toxicities in long-term survivors of malignancy following cerebral irradi..

Radiation-induced cavernomas: investigating the role of MRI-SWI for screening and surveillance in long-term cancer survivors

B Campbell, A Lasocki, M Bressel, S Oon, N Goroncy, J Seymour, M Dwyer, K Wiltshire, K Mason, D Tange, M Xu, G Wheeler

Conference Proceedings  |  2021  |  RADIOTHERAPY AND ONCOLOGY